CLINICAL_TRIALS
research
· 2025-12-12
Clinical Trial Update: RECLAIM Adaptive Platform Trial for PCC Treatments [Phase 3]
Summary
Phase 3 RECLAIM adaptive platform trial evaluating treatments for Post-COVID Condition; the study is currently enrolling by invitation.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Janneke van de Wijgert | Conditions: Post COVID Condition | Phase 3 | Status: ENROLLING_BY_INVITATION